Amtech Esters IPO Day 3: Subscribed 23.71x; QIB surges to 13.60x

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Amtech Esters IPO subscribed 23.71x on Day 3, up from 2.80x on Day 2.
  • QIB demand surged to 13.60x, jumping from 1.00x earlier in the day.
  • Retail subscription reached 25.93x, while NII (bHNI) hit 27.45x.
  • Allotment scheduled for 2026-09-15, listing on 2026-09-17.
powered bylight_fuzz_icon
50652204

*this image is generated using AI for illustrative purposes only.

Amtech Esters IPO subscription surged to 23.71x on Day 3, driven by a massive acceleration in Qualified Institutional Buyer (QIB) demand. QIB subscription jumped to 13.60x, while Retail investors pushed their bid to 25.93x.

Subscription Status

The issue saw significant momentum in the final hours of the bidding window. The total subscription rose from 1.13x on Day 1 to 2.80x on Day 2, before accelerating sharply to 23.71x on Day 3. The most notable development was the late-stage institutional interest, with QIBs entering the fray aggressively after remaining flat at 1.00x for the first two days.

Day Date QIB NII (bHNI) NII (sHNI) Retail Total
Day 1 09-09-2026 1.00x 0.30x 3.02x 0.77x 1.13x
Day 2 10-09-2026 1.00x 2.07x 4.58x 3.41x 2.80x
Day 3 11-09-2026 13.60x 27.45x 34.15x 25.93x 23.71x

Category-wise Breakdown

Non-Institutional Buyers (bHNI) led the overall subscription at 34.15x, followed closely by Small HNI (sHNI) at 27.45x and Retail at 25.93x. Qualified Institutional Buyers (QIB) saw a dramatic late-day surge, jumping from 1.00x to 13.60x. The Employee quota remained unsubscribed at 0x.

Intra-day Timeline

On the final day, 11-09-2026, subscription figures picked up pace significantly after the morning session. QIB demand exploded between 1:15 PM and 4:15 PM, rising from 3.62x to 13.60x. Retail also jumped +287.6% today (from 6.69x to 25.93x), while NII (bHNI) rose +511.4% today (from 4.49x to 27.45x). The total subscription jumped +375.2% today (from 4.99x to 23.71x).

Time (IST) QIB NII (bHNI) Retail Total
11:15 1.00x 4.49x 6.69x 4.99x
12:15 1.00x 5.68x 9.11x 6.46x
13:15 3.62x 7.80x 11.70x 9.06x
14:15 6.42x 11.20x 14.64x 12.30x
15:15 9.77x 18.20x 19.56x 16.94x
16:15 13.60x 27.45x 25.93x 23.71x

Offer Details

Amtech Esters priced its IPO between ₹71.00000 and ₹75.00000. The issue size ranges from ₹227200 lakhs to ₹500000 lakhs. The minimum bid quantity is set at 3200 shares. The bidding window opened on 2026-09-09 10:00:00 and closed on 2026-09-11 16:00:00.

What's Next

Allotment is scheduled for 2026-09-15. The shares are expected to list on 2026-09-17.

About the Company

Amtech Esters is engaged in the B2B business of manufacturing Unsaturated Polyester Resins (UPRs) and trading complementary products such as fiber resin, hardeners, silicons, and other ancillary items. Founded in 2002, the company provides an integrated sourcing solution across the resin and FRP value chain. Its wholly owned subsidiary, Croda Pigments Private Limited, manufactures pigments used as colourants and additives, creating operational synergies within the group. The company is led by Managing Director Ajit Singh Bawa.

Financial Highlights

The company reported consolidated revenue from operations of ₹40.67 crores for the fiscal year ending 31/03/2026, up from ₹36.89 crores in FY 2025. Total profit stood at ₹4.22 crores in FY 2026, compared to ₹3.72 crores in FY 2025.

Particulars FY 2026 (₹ crores) FY 2025 (₹ crores) FY 2024 (₹ crores)
Revenue from Operations 40.67 36.89 24.60
Total Profit 4.22 3.72 2.84
Total Assets 34.47 27.86 24.79

Objects of the Issue

The company intends to utilize the proceeds for:

  • Investment in wholly owned subsidiary Croda Pigments Private Limited by way of debt (₹8.81 crores) for capital expenditure and working capital requirements.
  • Repayment or prepayment of certain borrowings (₹4.20 crores).
  • Funding inorganic growth through unidentified acquisitions and general corporate purposes.

Risk Factors

Key risks identified in the DRHP include:

  • Significant Revenue Dependence on Single Product Category: 62.84% of revenue is derived from UPR.
  • Geographic Concentration: 89.78% of revenue comes from manufacturing operations concentrated in Haryana.
  • Regulatory Non-Compliance: Instances of delayed statutory filings, including ADT-1 delays of over 3,500 days.
  • High Trade Receivables: Debtor days increased to 92 days in FY 2026.
  • Customer Concentration: Top 10 customers represent 40.78% of revenue.

How might the late-stage QIB surge impact the listing premium and initial price volatility when Amtech Esters lists on September 17?

Given the heavy reliance on Unsaturated Polyester Resins (62.84% of revenue), how vulnerable is the company to raw material price fluctuations or sector-specific downturns post-IPO?

What specific criteria will Amtech Esters use to identify acquisition targets for its 'unidentified acquisitions' fund, and how might this affect near-term profitability?

like19
dislike

Amtech Esters IPO Day 2: Subscribed 2.8x; NII bHNI surges 305.9%

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Amtech Esters IPO subscribed 2.8x on Day 2
  • NII (bHNI) demand surged 305.9% to 2.07x
  • Retail subscription jumped 118.6% to 3.41x
  • Total subscription rose from 1.58x to 2.80x intraday
powered bylight_fuzz_icon
50565486

*this image is generated using AI for illustrative purposes only.

Amtech Esters IPO subscription surged to 23.71x on Day 3, driven by a massive acceleration in Qualified Institutional Buyer (QIB) demand. QIB subscription jumped to 13.60x, while Retail investors pushed their bid to 25.93x.

Subscription Status

The issue saw significant momentum in the final hours of the bidding window. The total subscription rose from 1.13x on Day 1 to 2.80x on Day 2, before accelerating sharply to 23.71x on Day 3. The most notable development was the late-stage institutional interest, with QIBs entering the fray aggressively after remaining flat at 1.00x for the first two days.

Day Date QIB NII (bHNI) NII (sHNI) Retail Total
Day 1 09-09-2026 1.00x 0.30x 3.02x 0.77x 1.13x
Day 2 10-09-2026 1.00x 2.07x 4.58x 3.41x 2.80x
Day 3 11-09-2026 13.60x 27.45x 34.15x 25.93x 23.71x

Category-wise Breakdown

Non-Institutional Buyers (bHNI) led the overall subscription at 34.15x, followed closely by Small HNI (sHNI) at 27.45x and Retail at 25.93x. Qualified Institutional Buyers (QIB) saw a dramatic late-day surge, jumping from 1.00x to 13.60x. The Employee quota remained unsubscribed at 0x.

Intra-day Timeline

On Day 2 (10-09-2026), subscription figures picked up pace after midday. NII (bHNI) jumped +305.9% today (from 0.51x to 2.07x) and Retail jumped +118.6% today (from 1.56x to 3.41x).

Time (IST) QIB NII (bHNI) Retail Total
11:15 1.00x 0.51x 1.56x 1.58x
12:15 1.00x 0.59x 1.77x 1.70x
13:15 1.00x 0.90x 2.19x 1.96x
14:15 1.00x 1.51x 2.45x 2.16x
15:15 1.00x 1.68x 2.70x 2.30x
16:15 1.00x 1.81x 3.04x 2.50x
17:15 1.00x 2.07x 3.41x 2.80x

Offer Details

Amtech Esters priced its IPO between ₹71.00000 and ₹75.00000. The issue size ranges from ₹227200 lakhs to ₹500000 lakhs. The minimum bid quantity is set at 3200 shares. The bidding window opened on 2026-09-09 10:00:00 and closed on 2026-09-11 16:00:00.

What's Next

Allotment is scheduled for 2026-09-15. The shares are expected to list on 2026-09-17.

About the Company

Amtech Esters is engaged in the B2B business of manufacturing Unsaturated Polyester Resins (UPRs) and trading complementary products such as fiber resin, hardeners, silicons, and other ancillary items. Founded in 2002, the company provides an integrated sourcing solution across the resin and FRP value chain. Its wholly owned subsidiary, Croda Pigments Private Limited, manufactures pigments used as colourants and additives, creating operational synergies within the group. The company is led by Managing Director Ajit Singh Bawa.

Financial Highlights

The company reported consolidated revenue from operations of ₹40.67 crores for the fiscal year ending 31/03/2026, up from ₹36.89 crores in FY 2025. Total profit stood at ₹4.22 crores in FY 2026, compared to ₹3.72 crores in FY 2025.

Particulars FY 2026 (₹ crores) FY 2025 (₹ crores) FY 2024 (₹ crores)
Revenue from Operations 40.67 36.89 24.60
Total Profit 4.22 3.72 2.84
Total Assets 34.47 27.86 24.79

Objects of the Issue

The company intends to utilize the proceeds for:

  • Investment in wholly owned subsidiary Croda Pigments Private Limited by way of debt (₹8.81 crores) for capital expenditure and working capital requirements.
  • Repayment or prepayment of certain borrowings (₹4.20 crores).
  • Funding inorganic growth through unidentified acquisitions and general corporate purposes.

Risk Factors

Key risks identified in the DRHP include:

  • Significant Revenue Dependence on Single Product Category: 62.84% of revenue is derived from UPR.
  • Geographic Concentration: 89.78% of revenue comes from manufacturing operations concentrated in Haryana.
  • Regulatory Non-Compliance: Instances of delayed statutory filings, including ADT-1 delays of over 3,500 days.
  • High Trade Receivables: Debtor days increased to 92 days in FY 2026.
  • Customer Concentration: Top 10 customers represent 40.78% of revenue.

Will the strong retail and NII demand on Day 2 carry over to the final day of subscription, potentially leading to a significant oversubscription?

How might the listing price reflect the current 2.8x subscription level given the company's reliance on a single product category for over 60% of its revenue?

What impact could the planned debt investment in subsidiary Croda Pigments have on Amtech Esters' consolidated financial health post-listing?

like19
dislike

More News on